Health Catalyst Inc. Stock News

Upgrades Loop Capital upgraded the previous rating for Aspen Technology Inc (NASDAQ:AZPN) from Hold to Buy. In the second quarter, Aspen Technology showed an EPS of $1.20, compared to $2.04 from the y

SALT LAKE CITY , March 10, 2022 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ: HCAT ), a leading provider of data and analytics technology and services to health care organizations, today announced an expansive, multi-year strategic partnership with Tallahassee Memorial HealthCare (TMH), a private, not-for-profit community healthcare system serving a 17-county region in North Florida and South Georgia . Together, Health Catalyst and TMH will work to implement a strategic, scalable analytics platform that will serve as a single source of truth across the organization''s disparate data sources. The partnership will also focus on helping TMH achieve its clinical improvement goals in areas … Full story available on Benzinga.com

The trading price of Health Catalyst Inc. (NASDAQ:HCAT) closed lower on Tuesday, March 08, closing at $24.32, -1.74% lower than its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << Traders who pay close attention to intraday price movement should know that it fluctuated between $24.03 … Here Is How Powerful Health Catalyst Inc. (NASDAQ: HCAT) Stock Is Read More »

Health Catalyst (NASDAQ:HCAT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 2 0 0 0 Last

HCAT earnings call for the period ending December 31, 2021.

HCAT earnings call for the period ending December 31, 2021.

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q4 2021 Results - Earnings Call Transcript

Health Catalyst (HCAT) delivered earnings and revenue surprises of 9.52% and 2.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst press release (HCAT): Q4 Non-GAAP EPS of -$0.19 beats by $0.02.Revenue of $64.72M (+21.7% Y/Y) beats by $1.55M.

SOUTH JORDAN, Utah, March 01, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2021.

Health Catalyst (HCAT) delivered earnings and revenue surprises of 9.52% and 2.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst (NASDAQ:HCAT) is scheduled to announce Q4 earnings results on Tuesday, March 1st, after market close.The consensus EPS Estimate is -$0.21 (-31.2% Y/Y) and the…

Axonics (AXNX) delivered earnings and revenue surprises of 5.56% and 6.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Cerner (CERN) delivered earnings and revenue surprises of 5.68% and 2.27%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?